RG
ALXN

Rikoon Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Rikoon Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$404K Hold
2,644
– – 0.11% 160
2020
Q4 		$413K Hold
2,644
– – 0.12% 149
2020
Q3 		$303K Hold
2,644
– – 0.09% 169
2020
Q2 		$297K Buy
+2,644
New +$281K 0.1% 164

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rikoon Group's ALXN Position: Q1 2021 in Review

Rikoon Group held its Alexion Pharmaceuticals (ALXN) position steady in Q1 2021 at 2,644 shares worth $404K. The position accounts for 0.11% of the portfolio, ranked #160.

Rikoon Group first reported a position in ALXN in Q2 2020 and has held it in 4 quarters since. The position peaked at $413K in Q4 2020. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Rikoon Group held 2,644 shares of Alexion Pharmaceuticals worth $404K as of Q1 2021.
  • Rikoon Group left its Alexion Pharmaceuticals share count unchanged in Q1 2021.
  • Alexion Pharmaceuticals made up 0.11% of Rikoon Group's portfolio in Q1 2021, its #160 holding.
  • Rikoon Group first reported a position in Alexion Pharmaceuticals in Q2 2020 and has held it in 4 quarters since.
  • Rikoon Group's Alexion Pharmaceuticals position peaked at $413K in Q4 2020.
  • 753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.